Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GW Pharmaceuticals
Pharma
Jazz's Epidiolex fails trial in treatment-resistant epilepsies
Jazz Pharmaceuticals' cannabidiol-based seizure drug Epidiolex has stumbled on its quest to secure approval in Japan.
Fraiser Kansteiner
Aug 23, 2024 10:18am
Jazz weighs options, including possible sale: Bloomberg
Oct 20, 2023 11:18am
NICE signs off on reimbursement for Jazz's cannabinoid med
Feb 1, 2023 11:52am
Actor tours the country helping other epilepsy carers
Nov 1, 2022 7:20am
Jazz must hash new plan for cannabis drug after MS trial failure
Jun 28, 2022 10:35am
Jazz Pharmaceuticals beefs up cannabinoid production in the U.K.
Mar 25, 2022 10:49am
